Atorvastatin inhibits the immediate-early response gene EGR1 and improves the functional profile of CD4<sup>+</sup>T-lymphocytes in acute coronary syndromes
Anna Severino(Università Cattolica del Sacro Cuore), Giovanna Liuzzo(Agostino Gemelli University Polyclinic), Ada Francesca Giglio(Università Cattolica del Sacro Cuore), Luigi M. Biasucci(Agostino Gemelli University Polyclinic), Vincenzo Pazzano(Università Cattolica del Sacro Cuore), Filippo Crea(Università Cattolica del Sacro Cuore), Aureliano Ruggio(Università Cattolica del Sacro Cuore), Chiara Zara(Università Cattolica del Sacro Cuore), Daniela Pedicino(Agostino Gemelli University Polyclinic), Francesco Trotta(Italian Medicines Agency), Giulia Angelini(Università Cattolica del Sacro Cuore), Davide Flego(Università Cattolica del Sacro Cuore), Simona Giubilato(Università Cattolica del Sacro Cuore), Claudia Lucci(Università Cattolica del Sacro Cuore), Mara Campioni(Università Cattolica del Sacro Cuore), Antonio Iaconelli(Agostino Gemelli University Polyclinic)
Cited by 11
Related Papers
Ischemia and No Obstructive Coronary Artery Disease (INOCA)
|Circulation|2017|745
Bariatric–metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial
|The Lancet|2023|338
Human <i>CHN1</i> Mutations Hyperactivate α2-Chimaerin and Cause Duane's Retraction Syndrome
|Science|2008|177
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials
|European Heart Journal|2021|150
Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
|Frontiers in Physiology|2019|130